Amneal Pharmaceuticals News and Activities

Presence

Amneal Pharmaceuticals develops, makes, and sells generic and specialty medicines, biosimilars, and injectable products. It serves healthcare providers, pharmacies, hospitals, and patients in the United States and other markets.

Amneal Pharmaceuticals products and services overview:

Generic medicines
Specialty medicines
Injectable products
Biosimilar medicines
Active ingredients

Revenue: ~$3 billion

Employees: 7,500

Headquarters: Bridgewater, United States (USA)

Amneal Pharmaceuticals is one of the...

Amneal Pharmaceuticals is a company listed under the stock ticker AMRX (US).

Amneal Pharmaceuticals has a direct presence in 2 countries.

Acquisition, funding and merger involving Amneal Pharmaceuticals.

Amneal Pharmaceuticals has announced the acquisition of Kashiv BioSciences (posted on April 22 2026).

Executives

View the org chart displaying its 37 main executives

Most searched biographies at Amneal Pharmaceuticals

Popular executive movements at Amneal Pharmaceuticals

Timothy Biggiani, who was Senior Director, Talent Acquisition, is promoted to Vice President, Talent (posted on April 9 2026).
Amitkumar Sharma has joined the company as Vice President, Human Resources (posted on September 8 2025).

Create your alert
to follow the executive moves at Amneal Pharmaceuticals.